Medication info

Dualset Sustained Release Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›75mg / 1 tablet
Manufacturer / importer
Jungheon Pharmaceutical Co., Ltd.
Appearance
Light yellow rectangular sustained-release film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201502972 · Approved 2015.05.18

This product's status changed to Expired on 2025.05.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 1 tablet is recommended. Thereafter, doses should be given at intervals of at least 12 hours, and the dose should not exceed 4 tablets per day. Do not administer this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, regular monitoring should be performed to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur with this medicine; therefore, closely monitor the patient's response and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, when tramadol is administered orally to older adults aged 75 years or older, the elimination half-life of tramadol increases by 17%; therefore, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Ingredients

Manufacturer
Jungheon Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 1 tablet is recommended. Thereafter, doses should be given at intervals of at least 12 hours, and the dose should not exceed 4 tablets per day. Do not administer this medicine for longer than necessary. If long-term administration is required because of the nature and severity of the disease, regular monitoring should be performed to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and drowsiness may occur with this medicine; therefore, closely monitor the patient's response and adjust treatment appropriately. Older adults: Administer the usual adult dose. However, when tramadol is administered orally to older adults aged 75 years or older, the elimination half-life of tramadol increases by 17%; therefore, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, its use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, its use is not recommended.

Precautions

This medication may put stress on the liver, so those who regularly consume more than three drinks of alcohol per day must consult a physician or pharmacist before using it. If a serious skin reaction occurs during the use of this medication, such as rash, itching, or blisters, discontinue use immediately and consult a healthcare professional. The inclusion of tramadol may increase the risk of seizures if the recommended dosage is exceeded; therefore, strict adherence to the dosage is required. Particular caution is required when used in conjunction with certain antidepressants or other central nervous system drugs, as this may increase the risk of seizures. For patients with compromised respiratory function or severe acute asthma, this medication may pose a risk of respiratory depression and should only be administered under the supervision of healthcare personnel. Concurrent use of this medication with alcohol or benzodiazepines may lead to severe drowsiness, respiratory depression, or coma, and such combination should be avoided. Patients with head injuries or brain disorders may experience worsening intracranial pressure or respiratory depression from this medication; thus, caution is necessary. Long-term use may lead to psychological and physical dependence due to the components of this medication, so the duration and dosage should be adjusted according to a physician's instructions. Since the acetaminophen component can burden the liver, patients with compromised liver function should only take this medication after consulting a physician. Those with specific genotypes may experience accelerated metabolism of this medication, increasing the risk of side effects; in such cases, dosage adjustments or alternative medications may be necessary. Children under 12 years of age or adolescents under 18 years who have undergone tonsillectomy or adenoidectomy should not take this medication, and adolescents aged 12 to 18 should avoid use if particular risk factors are present. Electrolyte disturbances like hyponatremia may occur, so elderly patients or those at risk should undergo regular blood tests. Patients with an allergic reaction to any component of this medication or with certain severe conditions should not take it, and if any unusual symptoms occur while taking the medication, immediate consultation with healthcare personnel is necessary. Caution is required when driving or operating machinery, as dizziness or drowsiness may occur. In the event of overdose, severe respiratory depression or liver damage may occur; therefore, adherence to the prescribed dosage is critical, and in case of overdose, contact medical institutions immediately.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, weakness, fatigue, flushing, chest pain, rigidity, syncope, withdrawal symptoms, hypertension, exacerbation of hypertension, hypotension, arrhythmia, palpitations, tachycardia, dizziness, headache, tremors, ataxia, convulsions, hypertonia, migraine, exacerbation of migraine, involuntary muscle contractions, paresthesia, confusion, vertigo, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, dry mouth, nausea, vomiting, dysphagia, bloody stools, tongue swelling, decreased appetite, anxiety, delirium, euphoria, insomnia, nervousness, drowsiness, forgetfulness, depersonalization, depression, substance abuse, dependence, emotional instability, hallucinations, erectile dysfunction, nightmares, abnormal thoughts, anemia, dyspnea, proteinuria, urinary disorders, oliguria, urinary retention, pruritus, rash, sweating, urticaria, abnormal liver function, weight loss, tinnitus, abnormal vision, chill, leukocytosis, rhinitis, nasopharyngitis, limb pain, arthralgia, muscle cramps, muscle weakness, myalgia, blurred vision, conjunctivitis, decreased immune response, sensory abnormalities, stupor, dysgeusia, involuntary muscle contractions, migraine, urinary disorders, hematuria, dark urine, anuria, urinary hesitancy, urinary incontinence, dry mouth, abdominal pain, abdominal discomfort, abdominal distension, upper abdominal discomfort, upper abdominal pain, peptic ulcer, belching, thirst, chest discomfort, facial swelling, chills, fever, peripheral edema, weakness, pallor, blood pressure fluctuations, cough, runny nose, urine positive for erythrocytes, blood pressure increase, palpitations, menstrual irregularities, breast cancer, injury, congestive heart failure, dizziness, stupor, speech impairment, loss of consciousness, recurrence of myocardial infarction, hypotension, multiple organ failure, intentional overdose, delirium, miosis, mydriasis, speech impairment, motor impairment, hypoglycemia, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, withdrawal symptoms, toxic skin necrosis, bronchospasm, allergic reactions, anaphylaxis, Stevens-Johnson syndrome, serotonin syndrome, withdrawal symptoms, paralytic ileus, cholecystitis, abnormal renal function values, gastrointestinal bleeding, heartburn, acute gastritis, cold, upper respiratory infection, generalized weakness, motion sickness, transient ischemic attack, lethargy, memory impairment, lack of effect, facial flushing, fever, edema, chest pain, rigidity, syncope

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from exposure to air and moisture. The storage temperature should be kept between 1 degree and 30 degrees Celsius, avoiding excessively hot or cold places.

Appearance and packaging

Appearance

Light yellow rectangular sustained-release film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.